At Real Peptides, we believe that every component of your research should be held to the highest standard
Put-GABA in neurodegeneration Astrocytic release of Put-GABA provides tonic inhibition, the release of which is amplified under conditions of excess Glu excitation (Hja et al., 2009, 2012
There are millions of people in markets around the world who are ready for more ways to find affordable, high-quality care
Conference Reports for NATAP The Liver Meeting Digital Experience AASLD November 13 - 16 - 2020 Back Tweet Efficacy and safety of subcutaneous semaglutide once-daily versus placebo in patients with nonalcoholic steatohepatitis Semaglutide Resolves NASH in Big Placebo-Controlled Trial AASLD The Liver Meeting Digital Experience, November 13-16, 2020 Mark Mascolini Semaglutide, a glucagon-like peptide-1 agonist (GLP-1RA) licensed for treatment of type 2 diabetes, resolved nonalcoholic steatohepatitis (NASH) without worsening fibrosis significantly more often than placebo at all 3 subcutaneous doses used in a 320-person 72-week trial [1]
19 Aging Skin GHK-Cu is another ingredient gaining increasing attention for potential topical use for aging skin
Madelung's Disease: Lipectomy or Liposuction